Elicio Therapeutics, Inc. (ELTX)

Elicio Therapeutics will go public soon, but the exact IPO date is still unknown.
IPO Price Range
$12.00 - $14.00
Shares Offered
3,076,924
Deal Size
$40.00M

Income Statement (Annual)

Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year 20202019
Selling, General & Admin
32.8
Research & Development
12.729.54
Operating Expenses
15.7212.34
Operating Income
-15.72-12.34
Other Expense / Income
-0.01-0.08
Pretax Income
-15.71-12.26
Net Income
-15.71-12.26
Net Income Common
-15.71-12.26
EBITDA
-15.52-12.15
Depreciation & Amortization
0.190.11
EBIT
-15.71-12.26
Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).